Daniel Magoon
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Molecular Biology top 5%
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
Papers in
- Hematology 16
- Acute Myeloid Leukemia Research 14
- Hematopoietic Stem Cell Transplantation 4
- Chronic Myeloid Leukemia Treatments 3
-
- Acute Lymphoblastic Leukemia research 7
- Co-authors
- Patrick A. Brown (20 shared papers)Edward Allan R. Sison (11 shared papers)Peter Valent (1 shared paper)Meredith J. Taylor (1 shared paper)Scott W. Lowe (1 shared paper)Katharina Blatt (1 shared paper)James E. Bradner (1 shared paper)Christopher Johns (1 shared paper)
- Journals
- Blood (10 papers)Oncotarget (3 papers)Pediatric Blood & Cancer (2 papers)Clinical Cancer Research (1 paper)Experimental Hematology (1 paper)
- Partner nations
- United StatesCanadaAustria
In The Last Decade
Daniel Magoon
21 papers receiving 1.9k citations
Daniel Magoon's Hit Papers
Peers
Comparison fields: 5 of 58
- Hematology 853
- Molecular Biology 1.5k
- Oncology 338
- Genetics 110
- Immunology 173
Countries citing papers authored by Daniel Magoon
This map shows the geographic impact of Daniel Magoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Magoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Magoon more than expected).
Fields of papers citing papers by Daniel Magoon
This network shows the impact of papers produced by Daniel Magoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Magoon. The network helps show where Daniel Magoon may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Magoon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Hit paper breakdown → | 2011 | 1479 |
| 2 | 2015 | 92 | |
| 3 | 2013 | 84 | |
| 4 | 2017 | 63 | |
| 5 | 2016 | 60 | |
| 6 | 2014 | 50 | |
| 7 | 2015 | 32 | |
| 8 | 2013 | 27 | |
| 9 | 2012 | 7 | |
| 10 | 2013 | 7 | |
| 11 | 2018 | 7 | |
| 12 | 2013 | 4 | |
| 13 | 2012 | 3 | |
| 14 | 2018 | 2 | |
| 15 | 2010 | 1 | |
| 16 | 2012 | 1 | |
| 17 | 2010 | 1 | |
| 18 | 2011 | 1 | |
| 19 | 2015 | 1 | |
| 20 | 2013 | 1 |
About Daniel Magoon
Daniel Magoon is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Molecular Biology and Genetics, having authored 22 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (7 papers), Chemokine receptors and signaling (6 papers), Hematopoietic Stem Cell Transplantation (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Retinoids in leukemia and cellular processes (2 papers), Renal and related cancers (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (853 citations), Molecular Biology (1.5k citations), Oncology (338 citations), Genetics (110 citations) and Immunology (173 citations). Daniel Magoon has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include Patrick A. Brown, Edward Allan R. Sison, Peter Valent, Meredith J. Taylor, Scott W. Lowe, Katharina Blatt, James E. Bradner, Christopher Johns, Amy Rappaport and Mark Wunderlich. Their work appears in journals such as Blood, Oncotarget, Pediatric Blood & Cancer, Clinical Cancer Research and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.